Search research articles
Contact Us
Filters
Showing results (261-270 of 284) with videos related to
Page
of 29
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 25, 2019
Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China
Yadong Du, Chao Qiu, Xiaohong Chen, et al.
Frontiers in Pharmacology
|
June 19, 2023
Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
Shanshan Li, Xiaojie Wu, Nanyang Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 10, 2020
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
Yameng Sun, Xiaoning Wu, Jialing Zhou, et al.
Human Vaccines & Immunotherapeutics
|
December 9, 2020
Genetic susceptibility to rotavirus infection in Chinese children: a population-based case-control study
Jin-Xia Wang, Li-Na Chen, Can-Jing Zhang, et al.
National Science Review
|
August 22, 2025
Integrated multi-omics characterization across clinically relevant subgroups of long COVID
Jingwen Ai, Jingxin Guo, Ke Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 19, 2020
Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis
Yang Li, Jie Wang, Yiqi Yu, et al.
The Journal of Infectious Diseases
|
December 27, 2023
Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection
Yi Zhang, Yang Zhou, Jiazhen Chen, et al.
Journal of Viral Hepatitis
|
August 6, 2019
Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment-naïve chronic hepatitis B patients
Qiran Zhang, Guojun Li, Yiqi Yu, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study
Xiaojie Wu, Nanyang Li, Guoqin Wang, et al.
Plos One
|
September 3, 2011
Early adaptive humoral immune responses and virus clearance in humans recently infected with pandemic 2009 H1N1 influenza virus
Chao Qiu, Di Tian, Yanmin Wan, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 284) with videos related to
Sort By:
Page
of 29
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 25, 2019
Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China
Yadong Du, Chao Qiu, Xiaohong Chen, et al.
Frontiers in Pharmacology
|
June 19, 2023
Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
Shanshan Li, Xiaojie Wu, Nanyang Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 10, 2020
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
Yameng Sun, Xiaoning Wu, Jialing Zhou, et al.
Human Vaccines & Immunotherapeutics
|
December 9, 2020
Genetic susceptibility to rotavirus infection in Chinese children: a population-based case-control study
Jin-Xia Wang, Li-Na Chen, Can-Jing Zhang, et al.
National Science Review
|
August 22, 2025
Integrated multi-omics characterization across clinically relevant subgroups of long COVID
Jingwen Ai, Jingxin Guo, Ke Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 19, 2020
Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis
Yang Li, Jie Wang, Yiqi Yu, et al.
The Journal of Infectious Diseases
|
December 27, 2023
Vaccination Shapes Within-Host SARS-CoV-2 Diversity of Omicron BA.2.2 Breakthrough Infection
Yi Zhang, Yang Zhou, Jiazhen Chen, et al.
Journal of Viral Hepatitis
|
August 6, 2019
Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment-naïve chronic hepatitis B patients
Qiran Zhang, Guojun Li, Yiqi Yu, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study
Xiaojie Wu, Nanyang Li, Guoqin Wang, et al.
Plos One
|
September 3, 2011
Early adaptive humoral immune responses and virus clearance in humans recently infected with pandemic 2009 H1N1 influenza virus
Chao Qiu, Di Tian, Yanmin Wan, et al.
Page
of 29